Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Infectious Diseases

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/529204PMID 18419471PMCID PMC2717621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Threonine-Rich Repeats Increase Fibronectin Binding in the Candida albicans Adhesin Als5p

  2006cited by this paper
• The Anti-Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis

  2006cited by this paper
• Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.

  2006cited by this paper
• Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity

  2005cited by this paper
• Mice with disseminated candidiasis die of progressive sepsis.

  2005cited by this paper
• The Anti-Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice

  2005cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Aluminium compounds for use in vaccines

  2004cited by this paper
• Parenchymal Organ, and Not Splenic, Immunity Correlates with Host Survival during Disseminated Candidiasis

  2003cited by this paper
• Corrigendum to “Aluminum salts in vaccines—US perspective” [Vaccine 20 (Suppl. 2) (2002) S18–S23]

  2002cited by this paper
• Aluminum salts in vaccines--US perspective.

  2002cited by this paper
• Evidence-Based Surgery Chirurgie factuelle Users ’ guides to the surgical literature : how to use an article about a diagnostic test

  2001cited by this paper
• Innate and adaptive immunity in Candida albicans infections and saprophytism

  2000cited by this paper
• Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.

  1994cited by this paper
• Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients?

  1994cited by this paper
• Adjuvants--a balance between toxicity and adjuvanticity.

  1993cited by this paper
• Users' guides to the medical literature.

  1993cited by this paper
• Aluminum salts.

  1992cited by this paper

• Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections

  2025cites this paper
• β-Glucan Chitosan Particle Provides Cross-Protection Against Multi-Drug- Resistant Candida auris

  2025cites this paper
• A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis.

  2024cites this paper
• The Road Ahead: Advancing Antifungal Vaccines and Addressing Fungal Infections in the Post-COVID World.

  2024cites this paper
• Identification of two anti-Candida antibodies associated with the survival of patients with candidemia

  2023cites this paper
• Genome-wide scan for potential CD4+ T-cell vaccine candidates in Candida auris by exploiting reverse vaccinology and evolutionary information

  2022cites this paper
• The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis

  2021cites this paper
• Advances in Fungal Peptide Vaccines

  2020cites this paper
• Structural basis of Blastomyces Endoglucanase-2 adjuvancy in anti-fungal and -viral immunity

  2020cites this paper
• Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria

  2020cites this paper
• Advances in Fungal Peptide Vaccines.

  2020cites this paper
• Fungal vaccines, mechanism of actions and immunology: A comprehensive review.

  2019cites this paper
• Monoclonal IgM antibodies raised against Candida albicans Hyr1 provide cross-kingdom protection against Gram negative bacteria

  2019cites this paper
• NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice

  2019cites this paper
• Targeting Glycans on Human Pathogens for Vaccine Design.

  2018cites this paper
• Invasive Fungal Disease in Critically Ill Patients at High Risk: Usefulness of Lymphocyte Subtyping

  2018cites this paper
• NDV-3A vaccination protects mice from Candida albicans biofilm infection

  2018cites this paper
• The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection

  2018cites this paper
• Human Als3p Antibodies are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis

  2018cites this paper
• Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells

  2018cites this paper
• Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis

  2018cites this paper
• The salivary gland as a target for enhancing immunization response

  2017cites this paper
• Metals in fungal virulence

  2017cites this paper
• The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections.

  2017cites this paper
• Innovative Approaches to Improve Anti-Infective Vaccine Efficacy.

  2017cites this paper
• Antifungal Activity of Plasmacytoid Dendritic Cells and the Impact of Chronic HIV Infection

  2017cites this paper
• Ligation of Dectin-2 with a novel microbial ligand promotes adjuvant activity for vaccination

  2017cites this paper
• Immunotherapy for Fungal Infections

  2017cites this paper
• Fungal Vaccines and Immunotherapeutics: Current Concepts and Future Challenges

  2017cites this paper
• Antibodies to Pseudogymnoascus destructans are not sufficient for protection against white-nose syndrome

  2015influential citation
• Vaccines in the treatment of invasive candidiasis

  2015cites this paper
• Immunotherapy of Fungal Infections

  2015cites this paper
• DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system.

  2015cites this paper
• Carbon Metabolism in Pathogenic Yeasts (Especially Candida ): The Role of Cell Wall Metabolism in Virulence

  2014cites this paper
• Emerging drugs and vaccines for Candidemia

  2014cites this paper
• Mycoses and Antifungals: reviewing the basis of a current problem that still is a biotechnological target for marine products

  2014cites this paper
• A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.

  2014cites this paper
• Antifungal Th Immunity: Growing up in Family

  2014cites this paper
• 6 T Cell Responses in Fungal Infections

  2014cites this paper
• Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans.

  2013cites this paper
• NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.

  2013cites this paper
• Molecular Immuno Immune response Innate Immunity Adaptive Immunity Complement Cytokines Macrophages Granulocytes Basophiles Mast cells Dendritic cells NK cells Antibodies T lymphocytes B lymphocytes Humoral Cellular Humoral Cellular

  2013cites this paper
• Dendritic cells and vaccine design for sexually-transmitted diseases.

  2013cites this paper
• Induced Lethality via Th 1 and Th 17 Cell-Membrane Vesicles Protects Bacteria Outer Escherichia coli Immunization with Lötvall ,

  2013cites this paper
• Development of vaccines for Candida albicans: fighting a skilled transformer

  2013cites this paper
• Immune resistance and tolerance to fungi.

  2013cites this paper
• Immunization with Escherichia coli Outer Membrane Vesicles Protects Bacteria-Induced Lethality via Th1 and Th17 Cell Responses

  2013cites this paper
• Recent progress in vaccines against fungal diseases.

  2012cites this paper
• Host Defense Pathways Against Fungi: The Basis for Vaccines and Immunotherapy

  2012cites this paper
• From memory to antifungal vaccine design.

  2012cites this paper
• Vaccines and Passive Immunity against Candidiasis

  2012cites this paper
• Mucosal Immunity to Candida albicans

  2012cites this paper
• A Novel Th Cell Epitope of Candida albicans Mediates Protection from Fungal Infection

  2012cites this paper
• Candida: What Should Clinicians and Scientists Be Talking About?

  2012cites this paper
• Epitope de cellule t de candida albicans

  2012cites this paper
• Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection.

  2011cites this paper
• Prospects for Development of a Vaccine to Prevent and Control Vaginal Candidiasis

  2011cites this paper
• Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis

  2011cites this paper
• Vaccines for invasive fungal infections

  2011cites this paper
• Chapter 1

  2011influential citation
• Immunity to fungal infections

  2011cites this paper
• Horizontal Transmission of Candida albicans and Evidence of a Vaccine Response in Mice Colonized with the Fungus

  2011cites this paper
• Candida albicans Als3, a Multifunctional Adhesin and Invasin

  2010cites this paper
• An insight into the antifungal pipeline: selected new molecules and beyond

  2010cites this paper
• Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein.

  2010cites this paper
• Human fungal pathogen Candida albicans in the postgenomic era: an overview

  2009cites this paper
• Search for correlates of protection

  2009cites this paper
• Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination1

  2009cites this paper
• This information is current as Vaccination and the Impact on Th Immunity and Proteins , Glycolipids , and Polysaccharides Aspergillus fumigatus Immune Sensing of and Luigina

  2009cites this paper
• Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

  2009cites this paper
• Immune Sensing of Aspergillus Fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination 1 Materials and Methods A. Fumigatus Strain and Infection the Journal of Immunology

  2009cites this paper
• Lin aureus Staphylococcus Mice against the Bacterium Recombinant N Terminus of Als 3 p Protects The Antifungal Vaccine Derived from the

  2008cites this paper
• A Decade of Advances and Challenges

  2008cites this paper
• Vaccines to prevent systemic mycoses: holy grails meet translational realities.

  2008cites this paper
• The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus

  2008cites this paper